We are live on
!
Find out more
QC
Quantessence Capital Portfolio holdings
AUM
$20.5M
1-Year Est. Return
71.02%
This Fund
S&P 500
This Quarter
Est. Return
+5.34%
1 Year Est. Return
+71.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$400M
AUM Growth
+$156M
(+64%)
Cap. Flow
+$166M
Cap. Flow
% of AUM
41.53%
Top 10 Holdings %
Top 10 Hldgs %
29.1%
Holding
490
New
266
Increased
41
Reduced
24
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$28.6M |
| 2 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$12.7M |
| 3 |
Pfizer
PFE
|
+$11M |
| 4 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$10.2M |
| 5 |
BECN
Beacon Roofing Supply, Inc.
BECN
|
+$9.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Paper
IP
|
+$11.1M |
| 2 |
iShares US Real Estate ETF
IYR
|
+$11.1M |
| 3 |
Meta Platforms (Facebook)
META
|
+$7.23M |
| 4 |
UMB Financial
UMBF
|
+$6.83M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$6.69M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.24% |
| 2 | Financials | 15.91% |
| 3 | Technology | 11.39% |
| 4 | Industrials | 10.54% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Mativ Holdings
MATV
$448M
| $209K | 0.05% |
+33,500
| New | +$274K |
|
|
OSG
277
Octave Specialty Group
OSG
$252M
| $206K | 0.05% |
+23,500
| New | +$248K |
|
|
CNR
278
Core Natural Resources Inc
CNR
$4.19B
| $205K | 0.05% |
+2,660
| New | +$225K |
|
279
Regal Rexnord
RRX
$14.2B
| $205K | 0.05% |
+1,800
| New | +$250K |
|
|
COOP
280
DELISTED
Mr. Cooper
COOP
| $203K | 0.05% |
+1,700
| New | +$178K |
|
281
Perdoceo Education
PRDO
$1.9B
| $201K | 0.05% |
+8,000
| New | +$213K |
|
282
Par Pacific Holdings
PARR
$3.88B
| $187K | 0.05% |
+13,100
| New | +$206K |
|
|
ATYR
283
aTyr Pharma
ATYR
$46.4M
| $186K | 0.05% |
+61,621
| New | +$225K |
|
284
ClearPoint Neuro
CLPT
$423M
| $185K | 0.05% |
+15,582
| New | +$242K |
|
|
NESR
285
National Energy Services Reunited Corp
NESR
$2.79B
| $179K | 0.04% |
+24,339
| New | +$210K |
|
|
TTAM
286
Titan America SA
TTAM
$3.16B
| $178K | 0.04% |
+13,165
| New | +$195K |
|
287
Ginkgo Bioworks
DNA
$481M
| $174K | 0.04% |
+30,550
| New | +$311K |
|
288
Fulgent Genetics
FLGT
$559M
| $171K | 0.04% |
+10,100
| New | +$172K |
|
|
AGNT
289
AGNT Inc
AGNT
$664M
| $154K | 0.04% |
+15,700
| New | +$167K |
|
290
Helix Energy Solutions
HLX
$1.46B
| $151K | 0.04% |
+18,200
| New | +$153K |
|
291
Gevo
GEVO
$397M
| $142K | 0.04% |
+122,614
| New | +$205K |
|
292
Amylyx Pharmaceuticals
AMLX
$2.05B
| $142K | 0.04% |
+40,134
| New | +$143K |
|
|
LOGC
293
DELISTED
ContextLogic
LOGC
| $139K | 0.03% |
+19,855
| New | +$148K |
|
294
Titan International
TWI
$516M
| $138K | 0.03% |
+16,500
| New | +$136K |
|
295
Oportun Financial
OPRT
$257M
| $137K | 0.03% |
+24,910
| New | +$137K |
|
296
Protalix BioTherapeutics
PLX
$191M
| $131K | 0.03% |
+51,243
| New | +$122K |
|
297
Gossamer Bio
GOSS
$66.5M
| $130K | 0.03% |
+118,349
| New | +$137K |
|
298
Roivant Sciences
ROIV
$25.2B
| $126K | 0.03% |
+12,513
| New | +$135K |
|
299
Abeona Therapeutics
ABEO
$345M
| $124K | 0.03% |
+26,087
| New | +$142K |
|
300
Expensify
EXFY
$166M
| $122K | 0.03% |
+40,000
| New | +$139K |
|
Similar funds
FS
BC
HAM
DP
SPC
IW
SRHG
MPW
Quantessence Capital's Q1 2025 Portfolio in Review
As of Q1 2025, Quantessence Capital held 490 positions worth $400M, up 64% from $244M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Quantessence Capital deployed $166M of net new capital in Q1 2025, opening 266 new positions and adding to 41 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 229,788 shares worth $30.3M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 5.7% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $11.1M trimmed.
- Quantessence Capital's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 229,788 shares worth $30.3M.
- Quantessence Capital added most to Beacon Roofing Supply, Inc. in Q1 2025, an estimated $9.88M increase.
- Quantessence Capital's biggest Q1 2025 reduction was iShares US Real Estate ETF, cutting an estimated $11.1M.
- Quantessence Capital fully exited International Paper in Q1 2025, selling an estimated $11.1M.
- Quantessence Capital's ten largest holdings make up 29% of its $400M portfolio in Q1 2025.
- Quantessence Capital opened 266 new positions and closed 158 in Q1 2025.
- Quantessence Capital's portfolio value rose 64% quarter-over-quarter to $400M.
Based on Quantessence Capital's 13F filing for Q1 2025, filed 15 May 2025.